Fox Kiser

Washington, United States Founded: 1986 • Age: 40 yrs
Consulting services are offered for pharmaceutical and biotechnology sectors.
Annual revenue - Latest available
Total funding $6.1M 2 rounds
Employees - Tracked headcount
Investors - Known backers
Products - Services tracked
Competitors 9 Brand Intelligence

About Fox Kiser

Fox Kiser is a company based in Washington (United States) founded in 1986. Fox Kiser has raised $6.06 million across 2 funding rounds. Fox Kiser operates in a competitive market with competitors including Indegene, Zuellig Pharma, IntegriChain, Fishawack and Clinigen, among others.

  • Headquarter Washington, United States
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
Operational Areas
Healthcare → Healthcare Services & Infrastructure Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Total Equity Funding
    $6.06 M (USD)

    in 2 rounds

  • Latest Funding Round
    $5.04 M (USD), Series A

    Apr 11, 2018

  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Fox Kiser

Fox Kiser has successfully raised a total of $6.06M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $5.04 million completed in April 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

Investments & Acquisitions by Fox Kiser

Investments
Premium access

Investment portfolio details for Fox Kiser

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Fox Kiser

Premium access

Detailed financials for Fox Kiser

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Fox Kiser Comparisons

Fox Kiser Primary company
Description
Consulting services are offered for pharmaceutical and biote...
Location
Washington, United States
Founded Year
1986
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for Fox Kiser

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Fox Kiser

Fox Kiser operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Indegene, Zuellig Pharma, IntegriChain, Fishawack and Clinigen, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Suite solutions are provided for payers and healthcare providers.
Locked Locked Locked
Healthcare access in Asia is enhanced by Zuellig Pharma.
Locked Locked Locked
Inventory, order and customer relationship management solution for life science suppliers.
Locked Locked Locked
Fully integrated cross-border services are delivered to global pharmaceutical organizations.
Locked Locked Locked
Specialty medicines are supplied via clinical trials and access programs.
Locked Locked Locked
Technology-based consultancy and product development services are provided.
Premium access

Detailed competitors of Fox Kiser

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Fox Kiser

Premium access

Complete news archive for Fox Kiser

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Fox Kiser

Fox Kiser was founded in 1986 and raised its 1st funding round 32 years after it was founded.

Fox Kiser is headquartered in Washington, United States. It is registered at Washington, District Of Columbia, United States.

Fox Kiser is a funded company, having raised a total of $6.06M across 2 funding rounds to date.

Fox Kiser was established in 1986 as a consulting firm focused on the pharmaceutical and biotechnology industries. Services encompass market strategy, legal advisory, partnership facilitation, and development support. Operations involve providing specialized guidance to clients in these sectors, drawing on decades of industry experience to address strategic and operational needs. The firm maintains an online presence at foxkiser.com.

Fox Kiser's top competitors include Indegene, Zuellig Pharma and IntegriChain.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available